Biliary tract cancer

Current Opinion in Gastroenterology

Volumn 16, Issue 5, 2000, Pages 437-443

  Cormier, Janice N ^a   Vauthey, Jean Nicolas ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; NITRIC OXIDE;

ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT CANCER; BILIARY TRACT ENDOSCOPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE; CHRONIC INFLAMMATION; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALIGNANT TRANSFORMATION; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY;

EID: 0034455521     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200009000-00009     Document Type: Article

References (52)

1. Cancer statistics, 1999
2. Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study
3. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography
4. Mechanisms of biliary carcinogenesis: A pathogenic multistage cascade toward cholangiocarcinoma
5. Biliary tract cancers
6. Risk factors for biliary tract carcinogenesis
7. Monolobar Caroli's disease and cholangiocarcinoma
8. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism
9. Gene therapy for pancreatic and biliary malignancies
10. Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin
11. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma
12. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: Involvement of transforming growth factor beta1
13. Diagnostic imaging of early gallbladder cancer: Retrospective study of 53 cases
14. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis
15. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis
16. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma
17. Value of percutaneous transhepatic portography before hepatectomy for hilar cholangiocarcinoma
18. HASTE MR cholangiography in the evaluation of hilar cholangiocarcinoma
19. MR cholangiography: Technical advances and clinical applications
20. Magnetic resonance cholangiopancreatography
21. Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures
22. A prospective evaluation of cytology from biliary strictures
23. How many biopsies should be performed during percutaneous transhepatic cholangioscopy to diagnose biliary tract cancer?
24. Pancreatic and biliary endoscopy
25. Diagnosis of the depth of invasion of gallbladder carcinoma by EUS
26. Outcomes after curative resections of cholangiocarcinoma
27. Proximal bile duct cancer: High resectability rate and 5-year survival
28. Management strategies in resection for hilar cholangiocarcinoma
29. Cholangiocarcinoma: A spectrum of intrahepatic, perihilar, and distal tumors
30. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection
31. Hilar cholangiocarcinoma: Patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system
32. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver
33. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus
34. Segmental liver resections for hilar cholangiocarcinoma
35. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: A histologic analysis of 62 resected cases
36. Extended resections for hilar cholangiocarcinoma
37. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma
38. S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract
39. The National Cancer Data Base report on carcinoma of the gallbladder, 1989-1995
40. Treatment of gallbladder cancer by radical resection
41. Should the bile duct be preserved or removed in radical surgery for gallbladder cancer?
42. Outcomes of aggressive treatment of stage IV gallbladder cancer and predictors of survival
43. Gallbladder carcinoma discovered during laparoscopic cholecystectomy: Aggressive reresection is beneficial
44. Outcome of extensive surgery for TNM stage IV carcinoma of the gallbladder
45. Proposal on the extent of lymph node dissection for gallbladder carcinoma
46. Intravenous and intra-arterial chemotherapeutic possibilities in biliopancreatic cancer
47. Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer
48. Future role of radiotherapy as a component of treatment in biliopancreatic cancers
49. Carcinoma of the extrahepatic biliary tract: Surgery and radiotherapy for curative and palliative intent
50. Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer
51. Photodynamic therapy of nonresectable cholangiocarcinoma
52. Photodymanic therapy for advanced bile duct cancer: Evidence for improved palliation and extended survival